BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34353901)

  • 1. Telomerase RNA recruits RNA polymerase II to target gene promoters to enhance myelopoiesis.
    García-Castillo J; Alcaraz-Pérez F; Martínez-Balsalobre E; García-Moreno D; Rossmann MP; Fernández-Lajarín M; Bernabé-García M; Pérez-Oliva AB; Rodríguez-Cortez VC; Bueno C; Adatto I; Agarwal S; Menéndez P; Zon LI; Mulero V; Cayuela ML
    Proc Natl Acad Sci U S A; 2021 Aug; 118(32):. PubMed ID: 34353901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase RNA-based aptamers restore defective myelopoiesis in congenital neutropenic syndromes.
    Martínez-Balsalobre E; García-Castillo J; García-Moreno D; Naranjo-Sánchez E; Fernández-Lajarín M; Blasco MA; Alcaraz-Pérez F; Mulero V; Cayuela ML
    Nat Commun; 2023 Sep; 14(1):5912. PubMed ID: 37737237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative defects in dyskeratosis congenita skin keratinocytes are corrected by expression of the telomerase reverse transcriptase, TERT, or by activation of endogenous telomerase through expression of papillomavirus E6/E7 or the telomerase RNA component, TERC.
    Gourronc FA; Robertson mM; Herrig AK; Lansdorp PM; Goldman FD; Klingelhutz AJ
    Exp Dermatol; 2010 Mar; 19(3):279-88. PubMed ID: 19558498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A non-canonical function of telomerase RNA in the regulation of developmental myelopoiesis in zebrafish.
    Alcaraz-Pérez F; García-Castillo J; García-Moreno D; López-Muñoz A; Anchelin M; Angosto D; Zon LI; Mulero V; Cayuela ML
    Nat Commun; 2014; 5():3228. PubMed ID: 24496182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttranscriptional modulation of TERC by PAPD5 inhibition rescues hematopoietic development in dyskeratosis congenita.
    Fok WC; Shukla S; Vessoni AT; Brenner KA; Parker R; Sturgeon CM; Batista LFZ
    Blood; 2019 Mar; 133(12):1308-1312. PubMed ID: 30728146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HuR regulates telomerase activity through TERC methylation.
    Tang H; Wang H; Cheng X; Fan X; Yang F; Zhang M; Chen Y; Tian Y; Liu C; Shao D; Jiang B; Dou Y; Cong Y; Xing J; Zhang X; Yi X; Songyang Z; Ma W; Zhao Y; Wang X; Ma J; Gorospe M; Ju Z; Wang W
    Nat Commun; 2018 Jun; 9(1):2213. PubMed ID: 29880812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells.
    Batista LF; Pech MF; Zhong FL; Nguyen HN; Xie KT; Zaug AJ; Crary SM; Choi J; Sebastiano V; Cherry A; Giri N; Wernig M; Alter BP; Cech TR; Savage SA; Reijo Pera RA; Artandi SE
    Nature; 2011 May; 474(7351):399-402. PubMed ID: 21602826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients.
    Agarwal S; Loh YH; McLoughlin EM; Huang J; Park IH; Miller JD; Huo H; Okuka M; Dos Reis RM; Loewer S; Ng HH; Keefe DL; Goldman FD; Klingelhutz AJ; Liu L; Daley GQ
    Nature; 2010 Mar; 464(7286):292-6. PubMed ID: 20164838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous TERC alone can enhance proliferative potential, telomerase activity and telomere length in lymphocytes from dyskeratosis congenita patients.
    Kirwan M; Beswick R; Vulliamy T; Nathwani AC; Walne AJ; Casimir C; Dokal I
    Br J Haematol; 2009 Mar; 144(5):771-81. PubMed ID: 19036115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TERT and TERC mutations detected in cryptic dyskeratosis congenita suppress telomerase activity.
    Terada K; Miyake K; Yamaguchi H; Miyake N; Yamanaka K; Kojima S; Ito E; Inokuchi K; Okada T
    Int J Lab Hematol; 2020 Jun; 42(3):316-321. PubMed ID: 32150348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygous telomerase RNA mutations found in dyskeratosis congenita and aplastic anemia reduce telomerase activity via haploinsufficiency.
    Marrone A; Stevens D; Vulliamy T; Dokal I; Mason PJ
    Blood; 2004 Dec; 104(13):3936-42. PubMed ID: 15319288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients.
    Gu BW; Apicella M; Mills J; Fan JM; Reeves DA; French D; Podsakoff GM; Bessler M; Mason PJ
    PLoS One; 2015; 10(5):e0127414. PubMed ID: 25992652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow skeletal stem/progenitor cell defects in dyskeratosis congenita and telomere biology disorders.
    Balakumaran A; Mishra PJ; Pawelczyk E; Yoshizawa S; Sworder BJ; Cherman N; Kuznetsov SA; Bianco P; Giri N; Savage SA; Merlino G; Dumitriu B; Dunbar CE; Young NS; Alter BP; Robey PG
    Blood; 2015 Jan; 125(5):793-802. PubMed ID: 25499762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyskeratosis congenita: telomerase, telomeres and anticipation.
    Marrone A; Walne A; Dokal I
    Curr Opin Genet Dev; 2005 Jun; 15(3):249-57. PubMed ID: 15917199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical inhibition of PAPD5/7 rescues telomerase function and hematopoiesis in dyskeratosis congenita.
    Shukla S; Jeong HC; Sturgeon CM; Parker R; Batista LFZ
    Blood Adv; 2020 Jun; 4(12):2717-2722. PubMed ID: 32559291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust DNA Damage Response and Elevated Reactive Oxygen Species in TINF2-Mutated Dyskeratosis Congenita Cells.
    Pereboeva L; Hubbard M; Goldman FD; Westin ER
    PLoS One; 2016; 11(2):e0148793. PubMed ID: 26859482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements.
    Du HY; Pumbo E; Ivanovich J; An P; Maziarz RT; Reiss UM; Chirnomas D; Shimamura A; Vlachos A; Lipton JM; Goyal RK; Goldman F; Wilson DB; Mason PJ; Bessler M
    Blood; 2009 Jan; 113(2):309-16. PubMed ID: 18931339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
    Marrone A; Dokal I
    Expert Rev Mol Med; 2004 Dec; 6(26):1-23. PubMed ID: 15613268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(A)-specific ribonuclease (PARN) mediates 3'-end maturation of the telomerase RNA component.
    Moon DH; Segal M; Boyraz B; Guinan E; Hofmann I; Cahan P; Tai AK; Agarwal S
    Nat Genet; 2015 Dec; 47(12):1482-8. PubMed ID: 26482878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of TERC haploinsufficiency on the inheritance of telomere length.
    Goldman F; Bouarich R; Kulkarni S; Freeman S; Du HY; Harrington L; Mason PJ; Londoño-Vallejo A; Bessler M
    Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17119-24. PubMed ID: 16284252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.